iTeos Therapeutics, Inc. ITOS
10.15 0.00 (+0.00%)
At closeAug 29, 2025, 4:00 PM EDT
10.15 Day range 10.15
52-week range unavailable
- YTD
- +32.16%
- 1 year
- -40.82%
ITOS revenue history
Revenue is income from the company’s ordinary business activities.
35,000,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 35,000,000 | 22,405,000 | 177.89% |
| FY 2023 | 2023-12-31 | 12,595,000 | -255,035,000 | -95.29% |
| FY 2022 | 2022-12-31 | 267,630,000 | -77,145,000 | -22.38% |
| FY 2021 | 2021-12-31 | 344,775,000 | 344,775,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-08-07T20:16:49.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.